$ISIS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IONIS PHARMACEUTICALS INC. Get notifications about new insider transactions in IONIS PHARMACEUTICALS INC for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 806 | 8,721 | 2,694 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 194 | 2,099 | 4,907 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 45.00 | 806 | 36,270 | 9,526 | 10.3 K to 9.5 K (-7.80 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 806 | 8,721 | 10,332 | 9.5 K to 10.3 K (+8.46 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 45.00 | 194 | 8,730 | 9,526 | 9.7 K to 9.5 K (-2.00 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 194 | 2,099 | 9,720 | 9.5 K to 9.7 K (+2.04 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 11.27 | 2,500 | 28,175 | 5,000 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 11.27 | 2,500 | 28,175 | 7,500 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 41.00 | 2,500 | 102,500 | 6,548 | 9 K to 6.5 K (-27.63 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 11.27 | 2,500 | 28,175 | 9,048 | 6.5 K to 9 K (+38.18 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 38.49 | 2,500 | 96,225 | 6,548 | 9 K to 6.5 K (-27.63 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 11.27 | 2,500 | 28,175 | 9,048 | 6.5 K to 9 K (+38.18 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,000 | 10,290 | 5,500 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 10,000 | 72,500 | 93,462 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 2,000 | 20,580 | 6,500 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 3,741 | 27,122 | 103,462 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 16,259 | 167,305 | 0 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 42.22 | 1,000 | 42,220 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.23 | 10,000 | 402,300 | 25,029 | 35 K to 25 K (-28.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 10,000 | 72,500 | 35,029 | 25 K to 35 K (+39.95 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 37.25 | 1,000 | 37,250 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 35.10 | 1,000 | 35,100 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 37.50 | 3,741 | 140,288 | 25,029 | 28.8 K to 25 K (-13.00 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 3,741 | 27,122 | 28,770 | 25 K to 28.8 K (+14.95 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 37.10 | 6,259 | 232,209 | 25,029 | 31.3 K to 25 K (-20.00 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 6,259 | 64,405 | 31,288 | 25 K to 31.3 K (+25.01 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 35.55 | 10,000 | 355,500 | 25,029 | 35 K to 25 K (-28.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 10,000 | 102,900 | 35,029 | 25 K to 35 K (+39.95 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 11.27 | 22,805 | 257,012 | 0 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 38.54 | 17,805 | 686,205 | 10,803 | 28.6 K to 10.8 K (-62.24 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 11.27 | 17,805 | 200,662 | 28,608 | 10.8 K to 28.6 K (+164.82 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 34.08 | 5,000 | 170,400 | 10,803 | 15.8 K to 10.8 K (-31.64 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 11.27 | 5,000 | 56,350 | 15,803 | 10.8 K to 15.8 K (+46.28 %) |
| Nov 09 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 11.27 | 5,000 | 56,350 | 22,805 | |
| Nov 09 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 34.00 | 5,000 | 170,000 | 10,803 | 15.8 K to 10.8 K (-31.64 %) |
| Nov 09 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 11.27 | 5,000 | 56,350 | 15,803 | 10.8 K to 15.8 K (+46.28 %) |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,000 | 10,290 | 8,500 | |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 10,000 | 102,900 | 16,259 | |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 36.61 | 1,000 | 36,610 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 36.61 | 10,000 | 366,100 | 25,029 | 35 K to 25 K (-28.55 %) |
| Oct 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 10,000 | 102,900 | 35,029 | 25 K to 35 K (+39.95 %) |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 2,000 | 20,580 | 9,500 | |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 20,000 | 205,800 | 26,259 | |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 36.05 | 2,000 | 72,100 | 2,170 | 4.2 K to 2.2 K (-47.96 %) |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 2,000 | 20,580 | 4,170 | 2.2 K to 4.2 K (+92.17 %) |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 36.02 | 20,000 | 720,400 | 25,029 | 45 K to 25 K (-44.42 %) |
| Sep 29 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 20,000 | 205,800 | 45,029 | 25 K to 45 K (+79.91 %) |
| Sep 23 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 2,000 | 20,580 | 11,500 | |
| Sep 23 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 20,000 | 205,800 | 46,259 | |
| Sep 23 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 35.50 | 2,000 | 71,000 | 2,170 | 4.2 K to 2.2 K (-47.96 %) |
| Sep 23 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 2,000 | 20,580 | 4,170 | 2.2 K to 4.2 K (+92.17 %) |
| Sep 23 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 35.50 | 20,000 | 710,000 | 25,029 | 45 K to 25 K (-44.42 %) |
| Sep 23 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 20,000 | 205,800 | 45,029 | 25 K to 45 K (+79.91 %) |
| Sep 06 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Option Exercise | M | 14.69 | 3,635 | 53,398 | 24,910 | |
| Sep 06 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Option Exercise | M | 7.25 | 8,865 | 64,271 | 0 | |
| Sep 06 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Sell | S | 30.05 | 3,635 | 109,232 | 16,693 | 20.3 K to 16.7 K (-17.88 %) |
| Sep 06 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | M | 14.69 | 3,635 | 53,398 | 20,328 | 16.7 K to 20.3 K (+21.78 %) |
| Sep 06 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Sell | S | 29.82 | 8,865 | 264,314 | 16,693 | 25.6 K to 16.7 K (-34.69 %) |
| Sep 06 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | M | 7.25 | 8,865 | 64,271 | 25,558 | 16.7 K to 25.6 K (+53.11 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | A | 24.42 | 16,000 | 390,720 | 16,000 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 0.00 | 312 | 0 | 0 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 0.00 | 1,803 | 0 | 3,801 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 312 | 0 | 76,458 | 76.1 K to 76.5 K (+0.41 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 667 | 0 | 76,146 | 75.5 K to 76.1 K (+0.88 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 667 | 0 | 75,479 | 74.8 K to 75.5 K (+0.89 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 469 | 0 | 74,812 | 74.3 K to 74.8 K (+0.63 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | A | 24.42 | 16,000 | 390,720 | 16,000 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 312 | 0 | 0 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 1,803 | 0 | 3,801 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 312 | 0 | 4,658 | 4.3 K to 4.7 K (+7.18 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 469 | 0 | 4,346 | 3.9 K to 4.3 K (+12.10 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 667 | 0 | 3,877 | 3.2 K to 3.9 K (+20.78 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 667 | 0 | 3,210 | 2.5 K to 3.2 K (+26.23 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 24.42 | 16,000 | 390,720 | 16,000 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 1,334 | 0 | 3,333 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 667 | 0 | 3,877 | 3.2 K to 3.9 K (+20.78 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 667 | 0 | 3,210 | 2.5 K to 3.2 K (+26.23 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 24.42 | 16,000 | 390,720 | 16,000 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 312 | 0 | 0 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 1,803 | 0 | 3,801 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 312 | 0 | 7,658 | 7.3 K to 7.7 K (+4.25 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 469 | 0 | 7,346 | 6.9 K to 7.3 K (+6.82 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 667 | 0 | 6,877 | 6.2 K to 6.9 K (+10.74 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 667 | 0 | 6,210 | 5.5 K to 6.2 K (+12.03 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | A | 24.42 | 16,000 | 390,720 | 16,000 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 0.00 | 2,740 | 0 | 4,738 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 667 | 0 | 6,221 | 5.6 K to 6.2 K (+12.01 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 937 | 0 | 5,554 | 4.6 K to 5.6 K (+20.29 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 667 | 0 | 4,617 | 4 K to 4.6 K (+16.89 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 469 | 0 | 3,950 | 3.5 K to 4 K (+13.47 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 24.42 | 16,000 | 390,720 | 16,000 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 312 | 0 | 0 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 1,803 | 0 | 3,801 | |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 312 | 0 | 33,780 | 33.5 K to 33.8 K (+0.93 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 469 | 0 | 33,468 | 33 K to 33.5 K (+1.42 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 667 | 0 | 32,999 | 32.3 K to 33 K (+2.06 %) |
| Jul 06 2016 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 667 | 0 | 32,332 | 31.7 K to 32.3 K (+2.11 %) |
| Jul 01 2016 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | J | 20.76 | 403 | 8,365 | 16,693 | 16.3 K to 16.7 K (+2.47 %) |
| Jul 01 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | J | 20.76 | 402 | 8,344 | 9,526 | 9.1 K to 9.5 K (+4.41 %) |
| Jul 01 2016 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | J | 20.76 | 309 | 6,414 | 8,002 | 7.7 K to 8 K (+4.02 %) |
| Jul 01 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | J | 20.76 | 217 | 4,504 | 6,548 | 6.3 K to 6.5 K (+3.43 %) |
| Jul 01 2016 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | J | 20.76 | 163 | 3,383 | 8,517 | 8.4 K to 8.5 K (+1.95 %) |
| Jul 01 2016 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | J | 20.76 | 403 | 8,365 | 2,138 | 1.7 K to 2.1 K (+23.23 %) |
| Jul 01 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | J | 20.76 | 213 | 4,421 | 10,803 | 10.6 K to 10.8 K (+2.01 %) |
| Jun 02 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 5.93 | 12,500 | 74,125 | 0 | |
| Jun 02 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Sell | S | 22.31 | 12,500 | 278,900 | 2,543 | 15 K to 2.5 K (-83.10 %) |
| Jun 02 2016 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 5.93 | 12,500 | 74,125 | 15,043 | 2.5 K to 15 K (+491.55 %) |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 1,000 | 10,820 | 5,101 | |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 45.00 | 1,000 | 45,000 | 9,124 | 10.1 K to 9.1 K (-9.88 %) |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 1,000 | 10,820 | 10,124 | 9.1 K to 10.1 K (+10.96 %) |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,000 | 10,290 | 13,500 | |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 10,000 | 102,900 | 66,259 | |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.30 | 500 | 23,150 | 2,170 | 2.7 K to 2.2 K (-18.73 %) |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 500 | 5,145 | 2,670 | 2.2 K to 2.7 K (+23.04 %) |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 45.95 | 500 | 22,975 | 2,170 | 2.7 K to 2.2 K (-18.73 %) |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 500 | 5,145 | 2,670 | 2.2 K to 2.7 K (+23.04 %) |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.30 | 5,000 | 231,500 | 25,029 | 30 K to 25 K (-16.65 %) |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 5,000 | 51,450 | 30,029 | 25 K to 30 K (+19.98 %) |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 45.95 | 5,000 | 229,750 | 25,029 | 30 K to 25 K (-16.65 %) |
| Apr 07 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 5,000 | 51,450 | 30,029 | 25 K to 30 K (+19.98 %) |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 500 | 5,145 | 14,500 | |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 9.22 | 500 | 4,610 | 0 | |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 10,000 | 102,900 | 76,259 | |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.75 | 500 | 20,375 | 2,170 | 2.7 K to 2.2 K (-18.73 %) |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 500 | 5,145 | 2,670 | 2.2 K to 2.7 K (+23.04 %) |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.72 | 500 | 20,360 | 2,170 | 2.7 K to 2.2 K (-18.73 %) |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 9.22 | 500 | 4,610 | 2,670 | 2.2 K to 2.7 K (+23.04 %) |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.72 | 5,000 | 203,600 | 25,029 | 30 K to 25 K (-16.65 %) |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 5,000 | 51,450 | 30,029 | 25 K to 30 K (+19.98 %) |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.75 | 5,000 | 203,750 | 25,029 | 30 K to 25 K (-16.65 %) |
| Apr 01 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 5,000 | 51,450 | 30,029 | 25 K to 30 K (+19.98 %) |
| Mar 24 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 1,000 | 10,820 | 6,101 | |
| Mar 24 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 45.40 | 1,000 | 45,400 | 9,124 | 10.1 K to 9.1 K (-9.88 %) |
| Mar 24 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 1,000 | 10,820 | 10,124 | 9.1 K to 10.1 K (+10.96 %) |
| Feb 22 2016 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 5.93 | 12,500 | 74,125 | 0 | |
| Feb 22 2016 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 5.93 | 12,500 | 74,125 | 74,343 | 61.8 K to 74.3 K (+20.21 %) |
| Feb 04 2016 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 938 | 0 | 1,874 | |
| Feb 04 2016 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 938 | 0 | 2,543 | 1.6 K to 2.5 K (+58.44 %) |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 363 | 0 | 1,087 | |
| Jan 19 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 354 | 0 | 708 |